Paclitaxel-Teva

Medicinal product

(Invented) name

Paclitaxel-Teva

Active substance (s)

Paklitakselis

Strength

6 mg/ml

Pharmaceutical form

koncentratas infuziniam tirpalui

Route (s) of administration

leisti į veną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

L01CD01, Paclitaxel

Marketing authorisation holder

Teva B.V., Nyderlandai

Date of authorisation

2005-09-30

Date of renewal

2009-04-10

Documents

0299 Pakuotės lapelis 2024 11 16.docx

0299 Paclitaxel_Teva PCS PL 2024 11 16.docx

Stage

Išregistruotas

Controlled?

No

Controlled substance type

Legal basis

10(1)

Procedure number

NL/H/0604/001

Marketing authorisation procedure

Savitarpio pripažinimo procedūra

Qualitative and quantitative composition

1 ml koncentrato yra	1 ml
Paklitakselis	6 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
14797	4637	1004637	buteliukas	5 ml N1		Receptinis	LT/1/05/0299/001	Netiekiama	-	-	No	-	-	Download
14798	4636	1004636	buteliukas	16,7 ml N1		Receptinis	LT/1/05/0299/002	Netiekiama	-	-	No	-	-
14799	4675	1004675	buteliukas	50 ml N1		Receptinis	LT/1/05/0299/003	Netiekiama	2024-10-30	-	No	-	-
20708	23676	1023676	buteliukas	25 ml N1		Receptinis	LT/1/05/0299/004	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2025-07-30	Išregistruotas
2009-04-10	Perregistruotas
2005-09-30	Registruotas